Imagine a young dancer, Vivian, whose passion for dance is threatened by a painful condition called scoliosis. This abnormal curvature of the spine, often detected in adolescents, can lead to severe back pain and limited mobility. For Vivian, it means sitting through school and dance competitions is a struggle.
Vivian's doctor recommends a groundbreaking surgery called vertebral body tethering (VBT), but her insurance provider, Aetna, refuses to cover it. They claim the procedure is experimental, citing a lack of long-term safety and efficacy data.
But here's the catch: VBT, though relatively new, has shown promising results. The FDA approved it in 2019, and many doctors, including the Scoliosis Research Society and the Pediatric Orthopedic Society of North America, advocate for its use in adolescents with growing spines.
Vivian's case is a prime example of the ongoing battle between medical innovation and insurance coverage. Her family has appealed Aetna's decision three times, but to no avail. With the ideal window for treatment closing, they've taken legal action, suing Aetna to compel them to cover the surgery.
The controversy lies in the differing opinions on the procedure's risks and benefits. Aetna cites higher complication rates and inferior outcomes compared to standard spinal fusion surgery. However, several surgeons who perform VBT disagree, arguing that the benefits have become clearer as they've learned to identify ideal candidates.
Dr. Daniel Hoernschemeyer, a pediatric orthopedic specialist, puts it bluntly: "That's a sad day for me when I see somebody who truly is an indicated, ideal candidate for the procedure and I cannot provide that."
The debate extends beyond Vivian's case. Surgeons report spending hours arguing with insurance companies over VBT denials. This is symptomatic of a larger issue: insurance companies' reluctance to adapt their coverage policies to include the latest medical advancements.
And this is the part most people miss: the human cost of these insurance battles. For Vivian, it's not just about the surgery; it's about her ability to continue dancing, her favorite activity.
So, where do we go from here? Should insurance companies cover VBT more often, considering the growing body of evidence supporting its effectiveness? Or is more research needed to convince them of its long-term safety and efficacy?
What's your take on this controversial issue? Share your thoughts in the comments below!
